Brokerages Set $36 Consensus Price Target as Analysts Slash Alkami Technology Targets to $25-$40

ALKTALKT

Ten brokerages rate Alkami Technology as a Moderate Buy with an average 12-month price target of $36. Major analysts including JPMorgan, Barclays and Goldman Sachs cut their targets to as low as $25, reflecting adjustments from prior highs up to $46.

1. Stock Plunge Highlights Resilient Subscription Model

Alkami Technology saw its share price decline by approximately 50% over the past year, but investors should focus on its subscription-based revenue model, which delivered quarterly revenue of $112.95 million, up 31.5% year-over-year. The cloud-native banking platform reported a negative EPS of $0.14, missing the consensus estimate by $0.29, but its recurring revenue streams and multi-tenant SaaS architecture underpin predictable cash flows and high customer retention among community banks and credit unions.

2. Analyst Consensus and Price Target Movement

Ten brokerages covering Alkami Technology have established a consensus rating of Moderate Buy, with one analyst recommending Sell, three at Hold and six at Buy. The average twelve-month price target stands at $36.00. Notable revisions include JPMorgan Chase & Co. lowering its target from $40.00 to $38.00 while maintaining an Overweight rating; Citizens JMP reducing its target from $46.00 to $40.00 with a Market Outperform call; Barclays cutting its target from $30.00 to $25.00 and assigning an Equal Weight rating; and Goldman Sachs trimming its objective from $29.00 to $26.00 with a Neutral stance.

3. Insider and Institutional Activity Underlines Confidence

Insider Douglas A. Linebarger disposed of 8,179 shares in December at an average of $20.34, netting roughly $166,360 and reducing his stake by 3.56% to 221,751 shares. Insiders collectively hold 18.10% of the company. Meanwhile, institutional investors have been active: SG Americas Securities boosted its stake by 735.1% to 213,979 shares valued at $4.94 million; Long Path Partners increased its position by 138.2% to 2,568,823 shares worth $63.81 million; Diversified Trust grew its holding by 21.0% to 41,117 shares valued at $949,000; Penbrook Management raised its position by 2.9% to 127,685 shares worth $2.95 million; and Dark Forest Capital initiated a new investment valued at $2.61 million. Institutions now own 54.97% of Alkami’s shares.

Sources

FD